Minireview: Extranuclear steroid receptors: Roles in modulation of cell functions

Molecular Endocrinology

Volumn 25, Issue 3, 2011, Pages 377-384

  Levin, Ellis R ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEAT SHOCK PROTEIN 27; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN KINASE B; STEROID RECEPTOR;

CARDIOVASCULAR SYSTEM; CELL FUNCTION; CELL MEMBRANE; CELL NUCLEUS; EPIGENETICS; GOLGI COMPLEX; HUMAN; IN VIVO STUDY; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; CELL NUCLEUS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID;

EID: 79952179448     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0284     Document Type: Short Survey

References (75)

1. Selye H 1950 Stress and the general adaptation syndrome. Br J Med 1:1383-1392
2. Szego CM, Davis JS 1967 Adenosine 3,5 -monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA 58:1711-1718
3. Levin ER 2009 Plasma membrane estrogen receptors. Trends Endocrinol Metab 20:477-482
4. Pedram A, Razandi M, Sainson RCA, Kim JK, Hughes CC, Levin ER 2007 A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282:22278-22288 (Pubitemid 47267344)
5. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP 2007 The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol 21:359-375 (Pubitemid 46184890)
6. Skildum A, Faivre E, Lange CA 2005 Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol Endocrinol 19:327-339 (Pubitemid 40223458)
7. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER 2003 Identification of a structural determinant for the membrane localization of ERα. Mol Cell Biol 23:1633-1646
8. Pedram A, Razandi M, Kim JK, O'Mahony F, Lee EY, Luderer U, Levin ER 2009 Developmental phenotype of a membrane only estrogen receptor α (MOER) mouse. J Biol Chem 284:3488-3495
9. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors derive from a single transcript: studies of ERα and ERβ expressed in CHO cells. Mol Endocrinol 13:307-319 (Pubitemid 29068005)
10. Kumar P, Wu Q, Chambliss KL, Yuhanna IS, Mumby SM, Mineo C, Tall GG, Shaul PW 2007 Direct interactions with Gαi and Gβγ mediate nongenomic signaling by estrogen receptor β. Mol Endocrinol 21:1370-1380 (Pubitemid 46984743)
11. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP 2001 Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8:269-280 (Pubitemid 32831545)
12. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F 2000 Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 19:5406-5417
13. Bagchi G, Wu J, French J, Kim J, Moniri NH, Daaka Y 2008 Androgens transduce the Gαs-mediated activation of protein kinase A in prostate cells. Cancer Res 68:3225-3231
14. Lutz LB, Cole LM, Gupta MK, Kwist KW, Auchus RJ, Hammes SR 2001 Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. Proc Natl Acad Sci USA 98:13728-31333
15. Gill A, Jamnongjit M, Hammes SR 2004 Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis. Mol Endocrinol 18:97-104 (Pubitemid 38073157)
16. Chen JQ, Delannoy M, Cooke C, Yager JD 2004 Mitochondrial localization of ERα and ERβ in human MCF-7 cells. Am J Physiol Endocrinol Metab 28:E1011-E1022 (Pubitemid 38668826)
17. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630 (Pubitemid 40354745)
18. Chami M, Oulès B, Szabadkai G, Tacine R, Rizzuto R, Paterlini-Bréchot P 2008 Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol Cell 32:641-651
19. Filardo EJ, Quinn JA, Bland KI, Frackelton Jr AR 2000 Estrogen induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, gpr30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660
20. Noel SD, Keen KL, Baumann DI, Filardo EJ, Terasawa E 2009 Involvement of G protein-coupled receptor 30 (GPR30) in rapid action of estrogen in primate LHRH neurons. Mol Endocrinol 23:349-359
21. Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, Wang ZY 2010 Involvement of estrogen receptor variant ERα36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 24:709-721
22. Levin ER 2009 GPR30: ER or collaborator? Endocrinology 150:1563-1565
23. Langer G, Bader B, Meøli L, Insensee J, Delbeck M, Noppinger PR, Otto C 2010 A critical review of fundamental controversies in the field of GPR30 research. Steroids 75:603-610
24. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162-11166 (Pubitemid 23354389)
25. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M 2000 Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development 127:4277-4291
26. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci USA 95:15677-15682 (Pubitemid 29018759)
27. Li L, Haynes MP, Bender JR 2003 Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100:4807-4812 (Pubitemid 36457810)
28. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF 2006 A variant of estrogen receptor-α, hER-36: transduction of estrogen and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA 103:9063-9068 (Pubitemid 43902533)
29. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, Gannon F 2000 Identification of a new isoform of the human estrogen receptor-α (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J 19:4688-4700
30. Thomas P 2008 Characteristics of membrane progestin receptor α (mPRα) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol 29:292-312
31. Sleiter N, Pang Y, Park C, Horton TH, Dong J, Thomas P, Levine JE 2009 Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release. Endocrinology 150:3833-3844
32. Peluso JJ, Romak J, Liu X 2008 Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulose cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology 149:534-543 (Pubitemid 351159360)
33. Peluso JJ, Gawkowska A, Liu X, Shioda T, Pru JK 2009 Progesterone receptor membrane component-1 regulates the development and cisplatin sensitivity of human ovarian tumors in athymic nude mice. Endocrinology 150:4846-4854
34. Peluso JJ, Liu X, Gawkowska A, Johnston-MacAnanny E 2009 Progesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulose/luteal cell survival but not progesterone secretion. J Clin Endocrinol Metab 94:2644-2649
35. van Biesen T, Luttrell LM, Hawes BE, Lefkowitz RJ 1996 Mitogenic signaling via G protein-coupled receptors. Endocr Rev 17:698-714 (Pubitemid 26425262)
36. Razandi M, Pedram A, Park ST, Levin ER 2003 Proximal events in ER signaling from the plasma membrane. J Biol Chem 278:2701-2712 (Pubitemid 36801351)
37. Santen RJ, Fan P, Zhang Z, Bao Y, Song RX, Yue W 2009 Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells. Steroids 74:586-594
38. Sen A, O'Malley K, Wang Z, Raf GV, DeFranco DB, Hammes SR 2010 Paxillin regulates androgen and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 285:28787-28795
39. Faivre EJ, Lange CA 2007 Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 27:466-480 (Pubitemid 46080117)
40. Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, Nagahashi M, Harikumar KB, Hait NC, Milstien S, Spiegel S 2010 Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem 285:10477-10486
41. Sukocheva O, Wadham C, Holmes A, Albanese N, Verrier E, Feng F, Bernal A, Derian CK, Ullrich A, Vadas MA, Xia P 2006 Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol 173:301-310
42. Fan L, Zhao Z, Orr PT, Chambers CH, Lewis MC, Frick KM 2010 Estradiol-induced object memory consolidation in middle-aged female mice requires dorsal hippocampal extracellular signal-regulated kinase and phosphatidylinositol 3-kinase activation. J Neurosci 30:4390-4400
43. Almeida M, Martin-Millan M, Ambrogini E, Bradsher III R, Han L, Chen XD, Roberson PK, Weinstein RS, O'Brien CA, Jilka RL, Manolagas SC 2010 Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERα. J Bone Miner Res 25:769-781
44. Hammes SR, Levin ER 2007 Extra-nuclear steroid receptors: nature and function. Endocr Rev 28:726-741 (Pubitemid 350294293)
45. Baekkeskov S, Kanaani J 2009 Palmitoylation cycles and regulation of protein function (Review). Mol Membr Biol 26:42-54
46. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M 2005 Palmitoylation-dependent estrogen receptor α membrane localization regulation by 17-β-estradiol. Mol Biol Cell 16:231-237 (Pubitemid 40028339)
47. Galluzzo P, Ascenzi P, Bulzomi P, Marino M 2008 The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor α-palmitoylation. Endocrinology 149:2567-2575 (Pubitemid 351577394)
48. Razandi M, Pedram A, Levin ER 2010 Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane. Mol Cell Biol 30:3249-3261
49. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER 2004 Plasma membrane estrogen receptors exist and function as dimers. Mol Endocrinol 18:2854-2865 (Pubitemid 39577911)
50. Zhang GF, Yanamala N, Lathrop KL, Zhang L, Klein-Seetharaman J, Srinivas H 2010 Ligand-independent anti-apoptotic function of estrogen receptor β in lung cancer cells. Mol Endocrinol 24:1737-1747
51. Zhang G, Liu X, Farkas AM, Parwani AV, Lathrop KL, Lenzner D, Land SR, Srinivas H 2009 Estrogen receptor β functions through nongenomic mechanisms in lung cancer cells. Mol Endocrinol 23:146-156
52. Pedram A, Razandi M, Levin ER 2006 Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20:1996-2009 (Pubitemid 44286700)
53. Pedram A, Razandi M, Aitkenhead M, Levin ER 2005 Estrogen inhibits cardiomyocyte hypertrophy in vitro: antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem 280:26339-26348 (Pubitemid 41022232)
54. Guo X, Razandi M, Pedram A, Kassab G, Levin ER 2005 Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors α and β. J Biol Chem 280:19704-19710 (Pubitemid 41379495)
55. Kim KH, Bender JR 2009 Membrane-initiated actions of estrogen on the endothelium. Mol Cell Endocrinol 308:3-8
56. Chow RW, Handelsman DJ, Ng MK 2010 Rapid actions of sex steroids in the endothelium. Endocrinology 151:2411-2422
57. Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, Korach KS, Shaul PW, Mangelsdorf DJ 2007 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med 13:1185-1192 (Pubitemid 47530633)
58. Billon-Galés A, Fontaine C, Filipe C, Douin-Echinard V, Fouque MJ, Flouriot G, Gourdy P, Lenfant F, Laurell H, Krust A, Chambon P, Arnal JF 2009 The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiol. Proc Natl Acad Sci USA 106:2053-2058
59. Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW 2010 Nonnuclear estrogen receptor α signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 120:2319-2330
60. Harrington WR, Kim SH, Funk CC, Madak-Erdogan Z, Schiff R, Katzenellenbogen JA, Katzenellenbogen BS 2006 Estrogen dendrimer conjugates that preferentially activate extranuclear, non-genomic versus genomic pathways of estrogen action. Mol Endocrinol 20:491-502 (Pubitemid 43291204)
61. Jazbutyte V, Arias-Loza PA, Hu K, Widder J, Govindaraj V, von Poser-Klein C, Bauersachs J, Fritzemeier KH, Hegele-Hartung C, Neyses L, Ertl G, Pelzer T 2008 Ligand-dependent activation of ER lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized SHR. Cardiovasc Res 77:774-781 (Pubitemid 351301861)
62. Pedram A, Razandi M, Lubahn D, Liu J, Vannan M, Levin ER 2008 Estrogen inhibits cardiac hypertrophy: role of estrogen receptor β to inhibit calcineurin. Endocrinology 149:3361-3369 (Pubitemid 351919609)
63. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER Estrogen receptor β inhibits cardiac fibrosis. Mol Endocrinol 10.1210/me.2010-0154
64. Björnström L, Sjöberg M 2005 Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19:833-842 (Pubitemid 40397050)
65. Kim MS, Kondo T, Takada I, Youn MY, Yamamoto Y, Takahashi S, Matsumoto T, Fujiyama S, Shirode Y, Yamaoka I, Kitagawa H, Takeyama K, Shibuya H, Ohtake F, Kato S 2009 DNA demethylation in hormone-induced transcriptional derepression. Nature 461:1007-1012
66. Bredfeldt TG, Greathouse KL, Safe SH, Hung MC, Bedford MT, Walker CL 2010 Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT. Mol Endocrinol 24:993-1006
67. Roozendaal B, Hernandez A, Cabrera SM, Hagewoud R, Malvaez M, Stefanko DP, Haettig J, Wood MA 2010 Membrane-associated glucocorticoid activity is necessary for modulation of long-term memory via chromatin modification. J Neurosci 30:5037-5046
68. Faivre EJ, Daniel AR, Hillard CJ, Lange CA 2008 Progesterone receptor rapid signaling mediates ser 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol Endocrinol 22:823-837 (Pubitemid 351482820)
69. Subtil-Rodriguez A, Millan-Ariño L, Quiles I, Ballaré C, Beato M, Jordan A 2008 Progesterone induction of the 11β-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking. Mol Cell Biol 28:3830-3849 (Pubitemid 351732916)
70. Daniel AR, Lange CA 2009 Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proc Natl Acad Sci USA 106:14287-14292
71. Guillermo P, Vicent A, Silvina N, Roser Z, Ballare C, Clausell J, Beato M Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin. Mol Endocrinol 1210/me.2010-0027
72. Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, Katzenellenbogen BS 2008 Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 22:2116-2127
73. Quiles I, Millán-Ariño L, Subtil-Rodriguez A, Miñana B, Spinedi N, Ballaré C, Beato M, Jordan A 2009 Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms. Mol Endocrinol 23:809-826
74. Pedram A, Razandi M, Evinger AJ, Kim JK, Lee E, Levin ER 2009 Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell 20:3374-3389
75. Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, Jameson JL 2002 An estrogen receptor (ER)α deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 16:2188-2201 (Pubitemid 35155533)